AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE

NARecruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

March 31, 2027

Conditions
Gastric Outlet Obstruction
Interventions
DEVICE

AXIOS(TM) Stent and Electrocautery Enhanced Delivery System

Patients who meet all the inclusion criteria and none of the exclusion criteria will have a EUS-guided gastroenterostomy (EUS-GE) using the AXIOS(TM) lumen-apposing Metal Stent for the management of symptoms associated with gastric outlet obstruction from malignant unresectable neoplasm

Trial Locations (10)

10065

RECRUITING

New York Presbyterian/ Weill Cornell Medical Center, New York

15213

RECRUITING

University of Pittsburg Medical Center, Pittsburgh

55905

ACTIVE_NOT_RECRUITING

Mayo Clinic, Rochester

98101

RECRUITING

Virginia Mason Medical Center, Seattle

200433

RECRUITING

Shanghai Changhai Hospital, Shanghai

02115

RECRUITING

Brigham and Women's Hospital, Boston

Unknown

RECRUITING

UZ Leuven, Leuven

ACTIVE_NOT_RECRUITING

Asian Institute of Gastroenterology, Hyderabad

01246-092

NOT_YET_RECRUITING

Instituto do Cancer do Estado de Sao Paulo, São Paulo

H3Z 2E9

RECRUITING

McGill University Health Care, Montreal

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT06174805 - AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE | Biotech Hunter | Biotech Hunter